Diabetic Drug Pioglitazone Linked to Bladder Cancer

A recent report in Diabetes Care (doi 10.2337/dc10-2412) suggests a link between pioglitzone and the development of bladder cancer.  This is preliminary, not definitive proof.  Further study may erase all concern about bladder cancer.  The only other diabetic drug in this class (thiazolidinediones) is rosiglitazone: its use was just recently drastically reduced by the Food and Drug Administration.

Will pioglitazone eventually be pulled from the market because of this?  How many will suffer from bladder cancer in the meantime?  Nobody knows at this point.

We have 11 classes of drugs to treat diabetes.  Would you believe we don’t know all the potential long-term adverse effects of most of these drugs?  It’s true.

To me, that’s more reason to control diabetes with diet modification, such as the Low-Carb Mediterranean Diet or Dr. Bernstein’s Diabetes Solution.

Steve Parker, M.D.


Filed under Uncategorized

4 responses to “Diabetic Drug Pioglitazone Linked to Bladder Cancer

  1. seshagiri

    Pioglitazone is one of the wonderful drugs in diabetes care. We need to wait and watch.

  2. balaji

    It was just in one trial bladder cancer was noted…We should not conclude or spread negative message…

    Pioglitazone is just one of the best drugs which is associated with life of millions of diabetic patients..

    Lets support pioglitazoe..

  3. Even the FDA in the U.S. is getting more nervous about pioglitazone and bladder cancer within the last couple weeks.

  4. Pingback: Oral Drugs for Type 2 Diabetes: Which Are The Best? | Diabetic Mediterranean Diet